#fda

- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and ...

- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and ...

- 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm ...

- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a phase III, ...

- PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group ...

President Joko Widodo (Jokowi) had asked the Food and Drug Administration (FDA) to strengthen its roles, with regard ...

- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on ...

- Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue ...

- Medrobotics Corp., a medical robotics company, announced today at the Royal Australasian College of Surgeons meeting ...

Vaccine producer Bio Farma said it would launch and sell biosimilar specially for breast cancer at a cheaper price. ...

- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of ...

- The results of a recent multi-center clinical study show, for the first time, that oral administration ...

- HSRx Biopharmaceutical, a leading developer of polyfunctional-powered combination drugs for infectious ...

- Mitsubishi Tanabe Pharma Corporation (TSE: 4508), and Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd ...

-Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the ...